NHS to Offer Weight-Loss Drug Wegovy to 1 Million for Heart Attack & Stroke Prevention
NHS England will offer semaglutide, a weight-loss drug, to approximately 1.2 million individuals at risk of cardiovascular events – heart attacks and strokes – even if they are not clinically ... Read More